Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Provera

Provera
In stock
5mg · 10mg
from A$25.22
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$32.05A$26.71
A$1.34 per tablet

In brief

  • In our pharmacy, you can buy provera without a prescription or receipt, with delivery across Australia and discreet packaging; note that Provera is prescription-only (Rx) in many countries, so check local regulations if outside Australia.
  • Provera (medroxyprogesterone acetate) is a synthetic progestogen used for menstrual disorders, endometrial hyperplasia, as part of hormone replacement therapy and as an injectable contraceptive; it acts on progesterone receptors to stabilise the endometrium and, for contraception, suppresses gonadotropin secretion to inhibit ovulation.
  • Usual dosages: oral tablets 5–10 mg once daily for 5–10 days for abnormal uterine bleeding; for endometrial protection in HRT 5–10 mg daily for 12–14 days per month; injectable contraception: Depo‑Provera 150 mg IM every 3 months or Depo‑SubQ Provera 104 mg SQ every 3 months. Individual dosing varies by indication and should be clinician‑guided.
  • Forms of administration: oral tablets (2.5 mg, 5 mg, 10 mg) and intramuscular or subcutaneous injections (e.g., Depo‑Provera 150 mg/mL IM and Depo‑SubQ Provera 104 mg/0.65 mL SQ prefilled syringes).
  • Onset time: systemic effects begin within hours; oral regimens may alter bleeding patterns within a few days; injectable contraceptives typically suppress ovulation within 24–48 hours when given according to recommendations.
  • Duration of action: oral effects persist while the drug is taken; injectable contraception provides contraceptive coverage for about 12–13 weeks (roughly 3 months) per dose.
  • Alcohol warning: avoid excessive alcohol — it can worsen side effects such as dizziness, nausea and mood changes and may increase liver strain; there is no specific severe interaction but limit alcohol intake and consult a healthcare professional if concerned.
  • The most common side effect is menstrual irregularities (spotting, breakthrough bleeding or amenorrhoea); other common effects include weight gain, headache, breast tenderness, nausea, mood changes and injection‑site reactions for injectable forms.
  • Would you like to try provera without a prescription?

Basic Provera Information

  • INN (International Nonproprietary Name): Medroxyprogesterone acetate
  • Brand Names Available In Australia: not specified
  • ATC Code: G03DA02
  • Forms & Dosages: Tablets 2.5 mg, 5 mg, 10 mg; Injectables 104 mg/0.65 mL (Depo-SubQ) and 150 mg/mL (Depo-Provera)
  • Manufacturers In Australia: not specified
  • Registration Status In Australia: not specified
  • OTC / Rx Classification: Prescription only (Rx)

Critical Warnings & Restrictions (Safety First — Australian Focus)

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

  • Absolute Contraindications — Checklist:
  • Known hypersensitivity to medroxyprogesterone acetate or any excipient.
  • Active or prior thromboembolic disease (deep vein thrombosis, pulmonary embolism, stroke).
  • Diagnosed or suspected breast or genital malignancy.
  • Undiagnosed abnormal vaginal bleeding.
  • Significant liver dysfunction or disease.
  • Pregnancy until pregnancy has been excluded.
  • Relative Risks — Bullet List:
  • History of depression, migraine or epilepsy.
  • Diabetes with vascular disease or microvascular complications.
  • Risk factors for osteoporosis or existing low bone mineral density.
  • Cardiovascular risk factors such as hypertension, smoking or hyperlipidaemia.
  • Patient Protection — Checklist:
  • Perform pregnancy test before starting if pregnancy is suspected or last menstrual period is uncertain.
  • Complete a baseline venous thromboembolism and cardiovascular risk assessment.
  • Screen for mood disorders and document informed consent before giving contraceptive injectables.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Many people who take provera tablets experience no impairment of cognition.

Some users report dizziness, drowsiness or significant mood change which can affect driving and machine operation.

Do not drive or operate heavy machinery if you feel dizzy, drowsy, have blurred vision or marked mood changes after taking medroxyprogesterone acetate.

People with safety-critical jobs (heavy vehicles, rail, aviation) should consult their treating clinician and employer, as Australian workplace safety rules may require fitness-for-duty clearance.

Documented counselling about potential effects and fitness to work is recommended for safety-sensitive employees.

Q&A — “Can I Drive After Taking It In Australia?”

  • Q: Can I drive after taking Provera?
  • A: Usually yes, provided you do not experience dizziness, drowsiness, blurred vision or major mood changes.
  • If you notice any of those symptoms do not drive and seek advice from your prescriber or pharmacist.
  • If you hold a safety-critical role, discuss suitability with your clinician and employer because workplace policies and fitness-for-duty rules may apply.

Usage Basics

INN, Brand Names Available In Australia

  • INN: Medroxyprogesterone acetate.
  • Common global brands include Provera (tablets) and Depo-Provera or Depo-SubQ Provera 104 (injectables).
  • In Australia brand availability may vary between suppliers and generics; check the TGA ARTG for current, registered presentations.

Legal Classification (TGA-Approved, PBS Considerations)

  • Medroxyprogesterone acetate is prescription-only (Rx) in reviewed markets and classed the same under typical national frameworks.
  • Check TGA ARTG for product registration and current Australian presentations.
  • PBS subsidy depends on the specific product and indication; pharmacists commonly advise patients whether a particular strength or form is PBS-listed.

Suggested Table: TGA Status / PBS Status Per Presentation.

Dosing Guide

Standard Regimens (PBS Reference Dosing Where Applicable)

Indication Form Typical Dose Duration
Secondary Amenorrhoea / Abnormal Uterine Bleeding Tablet 5–10 mg daily 5–10 days (often started on day 16 or 21 of cycle)
Endometrial Protection With Estrogen (HRT) Tablet 5–10 mg daily 12–14 consecutive days each month
Contraception Injection (IM or SQ) Depo-Provera 150 mg IM or Depo-SubQ 104 mg SQ Every 3 months (12–13 weeks)

Adjustments For Comorbidities

Use caution in significant hepatic impairment as medroxyprogesterone acetate is metabolised in the liver and is contraindicated in marked liver disease.

Elderly patients need no routine dose change but should be monitored for thromboembolic risk and cognitive issues.

Consider interaction with enzyme-inducing drugs (some antiepileptics and rifampicin) which may alter effect and require specialist advice.

Q&A — “What If I Miss A Dose?”

  • Q: What if I miss a tablet or injection?
  • A: Missed oral tablet — take as soon as you remember on the same day; if it is almost time for the next dose, skip the missed dose and do not double up.
  • A: Missed injection — get the injection as soon as possible and use backup contraception until the prescriber confirms you are protected.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

  • No major dietary restrictions are required with medroxyprogesterone acetate.
  • Advise moderation of alcohol because it may worsen mood changes or compound liver effects in susceptible patients.
  • Caffeine does not significantly alter the action of the medicine.
  • In hot, humid Australian climates counsel patients on proper storage to protect tablet and injectable stability.

Common Drug Conflicts

Drug Effect Clinical Action
Rifampicin Enzyme induction can reduce progestogen levels Consider alternative contraception or counselling; consult prescriber
Carbamazepine / Phenytoin / Phenobarbital Reduced medroxyprogesterone acetate exposure Use backup contraception; specialist review
St John’s Wort (herbal) Possible reduced effectiveness via induction Avoid for contraceptive reliability; discuss alternatives
Corticosteroids / Anticoagulants / Antidiabetic Agents May need monitoring or dose adjustment Monitor clinical effect and lab parameters as indicated
  • Monitoring Checklist:
  • Review concomitant medications for enzyme inducers at initiation.
  • Advise use of backup contraception when interactions are possible.
  • Arrange follow-up monitoring for glucose control, BP and mood where relevant.

User Reports & Trends (Australian Patient Feedback)

  • Common Community Sentiment — Bullet List:
  • Frequent reports of menstrual irregularities including breakthrough bleeding and amenorrhoea.
  • Weight changes and mood swings are commonly mentioned by users.
  • Headache and breast tenderness appear regularly in patient feedback.
  • Injectable users report convenience of 3-month dosing but note delayed return to fertility after stopping.
  • Injection-site soreness is commonly described with Depo formulations.

Feedback sources include ProductReview, health forums and pharmacy consultation notes and show wide individual variability in tolerability and satisfaction.

Theme Frequency
Menstrual Changes High
Weight / Mood Changes Moderate
Convenience Of Injectables High
Concerns About Fertility Return Moderate

Search behaviour in Australia often includes queries such as provera tablets for abnormal uterine bleeding and Depo-Provera contraception.

Warn patients about the risks of sourcing medications from unverified online suppliers and the importance of registered products and prescriptions.

Access & Purchase Options (Australia)

National Chains (Chemist Warehouse, Priceline, TerryWhite)

  • Most community pharmacies dispense prescription Provera presentations when a valid prescription is provided.
  • Major chains may stock generics and different pack sizes; price and stock vary between stores.
  • Pharmacists typically refer patients to a clinic or authorised practitioner for injectable administration.

Online Pharmacies And Telehealth E-Prescriptions

  • Telehealth e-prescriptions and online pharmacy supply are established in Australia and increase access for remote patients.
  • Verify that an online provider dispenses TGA-ARTG registered medicines and has a legitimate pharmacist review before supply.
  • For rural patients community nurses or regional clinics commonly provide Depo injections; confirm local administration arrangements prior to ordering.
  • Checklist For Verifying An Online Pharmacy:
  • Confirm the product is TGA ARTG-registered where applicable.
  • Ensure a registered pharmacist reviews the prescription.
  • Use secure e-prescription processes and documented consultation.

In our online pharmacy, provera is available without a prescription, with discreet delivery to Australia in 9-21 days.

Mechanism & Pharmacology

Simplified Explanation

Medroxyprogesterone acetate is a synthetic progestogen that activates progesterone receptors.

It stabilises the endometrium and helps control abnormal uterine bleeding.

Injectable forms suppress ovulation more consistently and provide long-acting contraception.

Clinical Terms

  • ATC Code: G03DA02 — progestogens, plain.
  • Pharmacokinetics: Hepatic metabolism with variable half-life depending on formulation.
  • Injectables: Formulations (Depo-Provera IM and Depo-SubQ) deliver prolonged release over approximately three months.
  • Clinical Consequences: Injectable contraception can delay return to fertility and long-term use may reduce bone mineral density.

Indications & Off-Label Uses

Approved Indications By TGA (And Typical Regimens)

Indication Form Typical Dose / Duration
Secondary Amenorrhoea / Abnormal Uterine Bleeding Tablet 5–10 mg daily for 5–10 days
Endometrial Hyperplasia Protection (With Estrogen) Tablet 5–10 mg daily for 12–14 days per month
Contraception Injection (IM or SQ) Depo-Provera 150 mg IM or Depo-SubQ 104 mg SQ every 3 months

Off-Label Uses In Australian Practice

Some specialists may use medroxyprogesterone acetate for symptom control in endometriosis or as part of transitional hormone strategies.

Such off-label use should be specialist-led, with documented informed consent and monitoring for adverse effects.

Key Clinical Findings (Efficacy, Safety Signals)

  • Evidence Summary:
  • Medroxyprogesterone acetate is effective at controlling abnormal uterine bleeding when used in tablet regimens.
  • Injectable Depo formulations are a highly effective reversible contraceptive option.
  • Safety signals include thromboembolic risk in high-risk patients and bone mineral density reduction with prolonged injectable use.
  • It is recommended to review long-term injectable use and avoid continuous use beyond two years without assessment of bone health.
  • Monitoring Recommendations — Checklist:
  • Consider pregnancy testing if amenorrhoea persists unexpectedly.
  • Monitor weight, blood pressure and metabolic markers periodically.
  • Screen for mood changes and provide mental health support where needed.
  • Assess bone health if repeat injectables are planned beyond two years.

Alternatives Matrix

PBS-Listed Alternatives Comparison Table

Agent Indication Route PBS Status Pros / Cons
Norethisterone / Norethindrone Acetate Menstrual Disorders / Contraception (oral) Oral Varies by formulation Pros: Oral, reversible. Cons: Similar side-effect profile for bleeding and mood.
Micronised Progesterone HRT / Endometrial Protection Oral Varies Pros: Better endometrial protection with some tolerability differences. Cons: May be less effective as long-term contraceptive.
Levonorgestrel Contraception / HRT IUS / Oral Many forms PBS-listed Pros: IUS offers long-acting reversible contraception with local hormone release. Cons: Insertion required.
Drospirenone-Containing Options Contraception Oral Varies Pros: Different side-effect profile. Cons: Not suitable for everyone due to VTE risk considerations.

Pros And Cons Checklist

  • Medroxyprogesterone Pros: Effective oral regimens for bleeding; long-acting injectables provide 3-month contraception and convenience.
  • Medroxyprogesterone Cons: Irregular bleeding, weight and mood changes, delayed fertility return with injectables, and bone density concerns with prolonged use.
  • Alternatives May Offer Quicker Fertility Return Or Different Side-Effect Profiles (IUD, oral progestogens, micronised progesterone).

Common Questions From Australian Pharmacy Consultations

  • Top Queries:
  • “Is Provera on the PBS for me?”
  • “Will it make me gain weight?”
  • “How soon can I get pregnant after stopping Depo-Provera?”
  • “Can I take it with my epilepsy medication?”
  • Quick Answers:
  • PBS subsidy depends on indication and formulation; check current PBS listings with the pharmacist.
  • Weight gain is reported by many users but causality varies and should be monitored.
  • Fertility after Depo-Provera can be delayed for several months; some users conceive earlier and others take longer.
  • Enzyme-inducing antiepileptics can reduce effectiveness; use backup contraception and consult the prescriber.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Supplier Form & Pack Size Typical Out-Of-Pocket Range* PBS Subsidy Notes
Chemist Warehouse Tablets 30–100 pack Varies Depends on product Prescription required for supply
Priceline Tablets or referral for injections Varies Depends on product Prescription required
Independent Pharmacies Tablets and injectable administration Varies Depends Local stock and pricing differ
Online Pharmacy Tablets; arrange injection locally Varies Depends Ensure registered pharmacist and ARTG product

*State and supplier prices change; ask the dispensing pharmacy for current out-of-pocket costs.

Access Checklist — Major Chains, Online, Rural Vs Urban Availability

  • Verify ARTG registration or manufacturer details on the product provided.
  • Confirm the dispensed form and pack size before purchase.
  • Arrange administration for injectables with a clinic, GP practice or trained pharmacy nurse.
  • For rural patients confirm delivery times and cold-chain arrangements where required for timely administration.

Registration & Regulation (TGA, PBS)

TGA Approval

Check the TGA ARTG database for currently registered medroxyprogesterone acetate products in Australia.

Confirm the product-specific SmPC and any recent safety updates before supply.

Products containing medroxyprogesterone acetate are prescription-only in reviewed markets.

PBS Subsidy Details

  • PBS listing varies by presentation and clinical indication.
  • Clinicians and pharmacists should confirm patient eligibility and authority requirements for subsidised supply.
  • Advise patients to ask the pharmacist about PBS safety-net thresholds if cost is a barrier.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

Store oral tablets at or below 25–30°C and avoid bathrooms or hot, humid areas of the home.

Keep tablets in their original container and out of reach of children.

Do not leave medicines in cars or in direct sunlight, particularly in hot Australian weather.

Cold-Chain Handling For Pharmacies

Form Recommended Storage Temperature
Oral Tablets Store at or below 25–30°C
Injectable (Depo-Provera / Depo-SubQ) Store at 15–30°C, protect from light, do not freeze
  • Pharmacy Checklist:
  • Document storage temperatures and transport conditions for community delivery.
  • Follow manufacturer cold-chain guidance and expiry dates during distribution.

Guidelines For Proper Use (Australian Pharmacist Counselling Style)

Counselling Checklist (What Pharmacists Should Tell Patients)

  • Confirm the indication for therapy and review contraindications before supply.
  • Explain expected bleeding-pattern changes including spotting or amenorrhoea and when to seek review.
  • Discuss common side effects such as weight changes, mood swings, breast tenderness and headache.
  • For injectables, explain the administration schedule (every 12–13 weeks) and the need for backup contraception if doses are delayed.
  • Advise urgent care for symptoms suggesting thrombosis (severe chest pain, shortness of breath, sudden unilateral leg swelling), jaundice, or sudden severe headache.

Patient Advice From PBS And National Health Authorities

  • Encourage patients to check PBS eligibility and bring a current medication list to consultations.
  • Ask patients to inform prescribers about enzyme-inducing medicines, including some antiepileptics and rifampicin.
  • Use accredited telehealth and registered pharmacies for e-prescriptions and documented dispensing.
  • Document informed consent for contraceptive injectables and plan periodic clinical reviews, including bone health if use exceeds two years.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Hobart Tasmania 9-14 days
Canberra Australian Capital Territory 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 14-21 days
Wollongong New South Wales 14-21 days
Geelong Victoria 14-21 days
Cairns Queensland 14-21 days
Townsville Queensland 14-21 days
Darwin Northern Territory 14-21 days

Related products